. 2021 Jan-Jun;11(1):27–31. doi: 10.5005/jp-journals-10018-1341
Copyright © 2021; Jaypee Brothers Medical Publishers (P) Ltd.
© The Author(s). 2021 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted use, distribution, and non-commercial reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Fig. 2.
Increase in production of IL-2, IFN-γ, and TNF-α in PBMC due to 12 administrations of Peg-IFN